Expedited Access to Biosimilars Act

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 2 Compare versions History 5 Sponsors

Reported to Senate Jul 27, 2026 · 1.6K words Open full page ↗

Calendar No. 520

119TH CONGRESS

2D SESSION

S. 1414

To amend the Public Health Service Act to provide that clinical studies

required for licensure of biological products as biosimilar shall not be

required to include the assessment of immunogenicity,

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.

Create a free account Sign in

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Introduced — base rate 2%, measured from US's completed sessions
Momentum -7 20/100 from the pace of recorded action
Time since last action -22 554 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.